Status and phase
Conditions
Treatments
About
The current trial will explore the safety of flibanserin in combination with Selective Serotonin Reuptake Inhibitors or Norepinephrine Serotonin Reuptake Inhibitors in a representative population of women with depressive and possible concurrent anxiety symptomatology.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Conditions which may interfere with the ability to participate include, but are not limited to:
Primary purpose
Allocation
Interventional model
Masking
111 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal